fbpx

Is the PCR Test Fit for Purpose? – 10 Fatal Errors

Advertisements

An International Consortium of Life-Science Scientists have submitted an open letter to the Editorial Board Eurosurveillance calling on the retraction of an article entitled “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR” – referred to as the “Corman-Drosten paper.

The reason for this letter is based up an “External peer review of the RT-PCR test to detect SARS-CoV2 which reveals 10 major scientific flaws at the molecular and methodological level: consequences for false positive results”.

Advertisements

Dr Kevin Corbett, one of the signatories states…

“Every scientific rationale for the development of that test has been totally destroyed by this paper. It’s like Hiroshima/Nagasaki to the Covid test,” he said. “When Drosten developed the test, China hadn’t given them a viral isolate. They developed the test from a sequence in a gene bank. Do you see? China gave them a genetic sequence with no corresponding viral isolate. They had a code, but no body for the code.

In the fish market,” he said, “it’s like giving you a few bones and saying that’s your fish. It could be any fish. Not even a skeleton. Here’s a few fragments of bones. That’s your fish.”

Nov 26th 2020,
To: Editorial Board Eurosurveillance
European Centre for Disease Prevention and Control (ECDC)
Gustav III:s Boulevard 40
16973 Solna
Sweden

Subject: External Review and request to retract the paper of Corman et al, published in Eurosurveillance January 23, 2020.

Dear editorial board Eurosurveillance,

We, an international consortium of life-science scientists, write this letter in response to the article “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR” published in Eurosurveillance (January 23rd, 2020) and co-authored by Victor M Corman , Olfert Landt , Marco Kaiser , Richard Molenkamp, Adam Meijer, Daniel KW Chu, Tobias Bleicker , Sebastian Brünink, Julia Schneider , Marie Luisa Schmidt , Daphne GJC Mulders , Bart L Haagmans , Bas van der Veer , Sharon van den Brink, Lisa Wijsman, Gabriel Goderski, Jean-Louis Romette, Joanna Ellis, Maria Zambon, Malik Peiris, Herman Goossens, Chantal Reusken, Marion PG Koopmans, and Christian Drosten.

This paper (hereafter referred to as “Corman-Drosten paper”), published by “Eurosurveillance” on 23 January 2020, describes an RT-PCR method to detect the novel Corona virus (also known as SARS-CoV2). After careful consideration, our international consortium of Life Science scientists found the Corman-Drosten paper is severely flawed with respect to its biomolecular and methodological design. A detailed scientific argumentation can be found in our review “External peer review of the RTPCR test to detect SARS-CoV2 reveals 10 major scientific flaws at the molecular and methodological level: consequences for false positive results”, which we herewith submit for publication in Eurosurveillance.

Further, the submission date and acceptance date of this paper are January 21st and January 22nd, respectively. Considering the severe errors in design and methodology of the RT-PCR test published by “Eurosurveillance”, this raises the concern whether the paper was subjected to peer-review at all.

A previous request from our side (Dr. P. Borger; email 26/10/2020) to the editors of “Eurosurveillance” to provide the peer review report of the Corman-Drosten paper has not been complied with. We have enclosed your email reply (dated 18/11/2020) indicating that you do not wish to disclose important information to solve this conundrum.

We are confident that you will take our scientific objections seriously and recognize that there is no alternative but to accept our request to retract the Corman-Drosten paper.

Sincerely,
Dr. Pieter Borger (MSc, PhD), Molecular Genetics, W+W Research Associate, Lörrach, Germany

Prof. Dr. Ulrike Kämmerer, specialist in Virology / Immunology / Human Biology / Cell Biology, University Hospital Würzburg, Germany

Prof. Dr. Klaus Steger, Department of Urology, Pediatric Urology and Andrology, Molecular Andrology, Biomedical Research Center of the Justus Liebig University, Giessen, Germany

Prof. Dr. Makoto Ohashi, Professor emeritus, PhD in Microbiology and Immunology, Tokushima University, Japan

Prof. Dr. med. Henrik Ullrich, specialist Diagnostic Radiology, Chief Medical Doctor at the Center for Radiology of Collm Oschatz-Hospital, Germany

Rajesh K. Malhotra (Artist Alias: Bobby Rajesh Malhotra), Former 3D Artist / Scientific Visualizations at CeMM – Center for Molecular Medicine of the Austrian Academy of Sciences (2019-2020), University for Applied Arts – Department for Digital Arts Vienna, Austria

Dr. Michael Yeadon BSs(Hons) Biochem Tox U Surrey, PhD Pharmacology U Surrey. Managing Director, Yeadon Consulting Ltd, former Pfizer Chief Scientist, United Kingdom

Dr. Kevin P. Corbett, MSc Nursing (Kings College London) PhD (London South Bank) Social Sciences (Science & Technology Studies) London, England, UK

Dr. Clare Craig MA, (Cantab) BM, BCh (Oxon), FRCPath, United Kingdom

Kevin McKernan, BS Emory University, Chief Scientific Officer, founder Medical Genomics, engineered the sequencing pipeline at WIBR/MIT for the Human Genome Project, Invented and developed the SOLiD sequencer, awarded patents related to PCR, DNA Isolation and Sequencing, USA

Dr. Lidiya Angelova, MSc in Biology, PhD in Microbiology, Former researcher at the National Institute of Allergy and Infectious Diseases (NIAID), Maryland, USA

Dr. Fabio Franchi, Former Dirigente Medico (M.D) in an Infectious Disease Ward, specialized in “Infectious Diseases” and “Hygiene and Preventive Medicine”, Società Scientifica per il Principio di Precauzione (SSPP), Italy

Dr. med. Thomas Binder, Internist and Cardiologist (FMH), Switzerland

Dr. Stefano Scoglio, B.Sc. Ph.D., Microbiologist, Nutritionist, Italy

Dr. Paul McSheehy (BSc, PhD), Biochemist & Industry Pharmacologist, Loerrach, Germany

Dr. Marjolein Doesburg-van Kleffens, (MSc, PhD), specialist in Laboratory Medicine (clinical chemistry), Maasziekenhuis Pantein, Beugen, the Netherlands

Dr. Dorothea Gilbert (MSc, PhD), PhD Environmental Chemistry and Toxicology. DGI Consulting Services, Oslo, Norway

Dr. Rainer Klement, PhD. Department of Radiation Oncology, Leopoldina Hospital Schweinfurt, Germany

Dr. Ruth Schrüfer, PhD, human genetics/ immunology, Munich, Germany,

Dr. Berber W. Pieksma, General Practitioner, The Netherlands,

Dr. med. Jan Bonte (GJ), Consultant Neurologist, the Netherlands, Dr. Bruno

H. Dalle Carbonare (Molecular biologist), IP specialist, BDC Basel,
Switzerland.

Analysis

The question surrounding the efficacy of the PCR test is one of vital importance given that it is now the main driver of this “Pandemic” or should we call it “Casedemic”?

Mass population testing is a flawed idea in search of science to back it up. The inventor of the PCR test has stated this test should never be used as a tool in “the diagnosis of infectious diseases.”

Will the truth ever be revealed to the public, or is this now politically just too big to fail?

https://cormandrostenreview.com/retraction-request-letter-to-eurosurveillance-editorial-board/

https://uncoverdc.com/2020/12/03/ten-fatal-errors-scientists-attack-paper-that-established-global-pcr-driven-lockdown/

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045

https://unitynewsnetwork.co.uk/your-coronavirus-test-is-positive-but-what-does-that-mean/

Leave a Reply

-->
>